Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
-
Ass.-Prof. Dr.rer.nat. Michael Dengler
- Klinische Abteilung für Onkologie
- Email: michael.dengler(at)medunigraz.at
- Tel: +43/316/385/31428
- https://onkologie.medunigraz.at/en/research/identifying-new-cancer-drivers
- MEDonline-Visitenkarte
- Externe ID's
- ORCiD: 0000-0002-1693-1761
Wissenschaftszweige, Statistik Austria Klassifikation
- Zellbiologie - (301114)
- Drug Targeting - (301213)
- Medizinische Molekularbiologie - (301306)
- Krebsforschung - (301904)
- Onkologie - (302055)
Laufbahn
| 2022 -now | Tenure Track (Assistant) Professor for "Functional Precision Oncology", Division of Oncology, Medical University Graz, Austria |
| 2021 -2022 | University Assistant/Junior Group Leader, Division of Oncology, Medical University Graz, Austria |
| 2014 -2021 | Postdoc/Senior Postdoc, The Walter & Eliza Hall Institute of Medical Research, Melbourne, Australia |
| 2010 -2014 | Doctoral studies, Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart; and University of Stuttgart |
| 2003 -2009 | Studies in Technical Biology, University of Stuttgart, Germany |
Auszeichnungen
| 2022 | Start Funding - Medical University of Graz |
| 2018 | Science/Medicine Grant from CASS Foundation (Contributing to Australian Scholarship and Science) |
| 2016 | Walter & Eliza Hall Institute Postdoc Association International Travel Fellowship |
| 2014 | PhD with summa cum laude from University of Stuttgart, Germany |
| 2011 | American Society of Hematology (ASH) Abstract Achievement Award, 53rd ASH Annual Meeting, San Diego, USA |
Fachgutachter für wissenschaftliche Zeitschrift
| 2018 -2023 | CELL DEATH & DISEASE |
| 2019 -2022 | BLOOD |
| 2022 -2022 | THE FEBS JOURNAL |
| 2017 -2017 | LEUKEMIA & LYMPHOMA |
| 2017 -2017 | MOLECULAR ONCOLOGY |
| 2016 -2016 | ONCOGENE |